跳至主要内容
临床试验/CTRI/2024/03/064419
CTRI/2024/03/064419尚未招募2 期

Effect of Triphala Guggulu orally along with Darvi Taila Yoni Pichu in the management of Chronic Cervicitis - NI

Faculty of Ayurveda Institute of Medical Sciences BH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Only married women of different age group and parity.
  • 2. Patients presenting with at least any 3 of the following clinical signs and symptomatology
  • of chronic Cervicitis like -
  • a. Patients presenting with mucopurulent discharge p/v and endocervical bleed.
  • b. Patients having inflammatory Cervical Pap smear.
  • c. Patients presenting with clinical features of dyspareunia and cervical tenderness.
  • d. Patients presenting with clinical features of cervical congestion /strawberry cervix.
  • e. Patients presenting with intermenstrual/ post coital bleeding.
  • f. Patients presenting with other symptoms of cervicitis like back ache and lower
  • abdominal pain.

排除标准

  • 1. Unmarried
  • 2. Pregnant women and Patients suffering from any specific organic lesions such as
  • Tuberculosis, acute or chronic respiratory diseases, cardiac diseases, renal diseases,
  • Diabetes mellitus, Hypertension etc.
  • 3. Women with carcinoma of cervix, benign or malignant growth of reproductive tract, any
  • degree of genital prolapses.
  • 4. Patients having their HIV and VDRL reactive.
  • 5. Patients with Cervical Pap smear showing either CIN or papilloma virus infection or
  • invasive malignancy.
  • 6. Patients having Acute cervicitis.
  • 7. Patients having Acute Pelvic inflammatory disease.
  • 8. Patients with h/o surgery of cervix.

研究者

发起方
Faculty of Ayurveda Institute of Medical Sciences BH

相似试验

终止
3 期
Melatonin to improve induction of labour: a double blind, randomised, placebo controlled trial.
ACTRN12616000311459Monash Health187
进行中(未招募)
1 期
A double blind, randomised, placebo controlled trial of the time to onset meaningful of pain relief in subjects with post herpetic neuralgia (PHN) treated with pregabalin (150-600 mg /day flexible optimised dose or 300 mg/day fixed dose) or placebo - n/a
EUCTR2004-002563-24-ESPFIZER, S.A.255
已完成
不适用
A double blind, randomised, placebo controlled trial investigating the efficacy and role of Synbiotic Cocktail 2000 in the treatment of Clostridium difficile diarrhoea and colitis
ISRCTN10171652Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)120
进行中(未招募)
1 期
A double blind, randomised, placebo controlled trial to study the clinical effectiveness of Angiotensin Converting Enzyme (ACE) inhibitors, ramipril,in patients with intermittent claudication - ACE Inhibitor Clinical Effectiveness in ClaudicantsIntermittent Claudication
EUCTR2009-016600-23-GBHull and East Yorkshire Hospitals NHS Trust
进行中(未招募)
1 期
A double blind, randomised, placebo controlled trial of the time to onset of meaningful pain relief in subjects with post herpetic neuralgia (PHN) treated with pregabalin (150-600 mg /day flexible optimised dose or 300 mg/day fixed dose) or placebo - n/apost herpetic neuralgiaMedDRA version: 7Level: LLTClassification code 10036376
EUCTR2004-002563-24-GBPfizer Ltd255